Needs, expectations and doubt users of hormonal contraceptives
article
OA: gold
CC0
⤵ 2 in-corpus citations
Abstract
Description. The review is presented by modern publications, reflecting the importance of high-quality patient counseling when choosing a method of contraception and the factors that influence it. The choice of combined oral contraceptive (COC) is determined by the need for reliable and safe contraception, expectations for an improved quality of life, and doubts about the frequency of side effects and effects on reproductive and somatic health. Modern COCs containing natural hormone (estradiol valerate), a new gestagen (dienogest) with a dynamic regime and a shortened hormone-free interval (2 days) satisfy the COC requirements of most women from menarche to menopause when contraception is required. An improvement in the profile of menstrual bleeding (a decrease in blood loss in 88% of users) and sexual functioning (increased libido, arousal, and maintaining the cyclical nature of sexual behavior) has been shown. Estradiol valerate does not affect metabolism, has a low risk of thromboembolic events (the adjusted risk of venous thromboembolism compared to other COCs is 0.4) and a low frequency of failure due to side effects (1.7%). This tool is characterized by high efficiency (adjusted Pearl index 0.42) and user satisfaction (78.180.2%).
Conclusion. COCs with estradiol valerate/dinogest in 26/2 mode, fully satisfying the requirements of women for contraception, contributes to high adherence to it, that is, consistent and correct use, which contributes to the long-term use of the selected COC and ensures the quality of life of women for many years.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (25)
- Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel via openalex
- Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest via openalex
- Effect of a new oral contraceptive with estradiol valerate/dienogest on carbohydrate metabolism via openalex
- Effect of Estradiol valerate plus dienogest on body composition of healthy women in the menopausal transition: a prospective one-year evaluation via openalex
- Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: Results from the multicentre, randomised, double-blind, active-controlled HARMONY II study via openalex
- Effects of estroprogestins containing natural estrogen on vaginal flora via openalex
- Efficacy and bleeding profile of a combined oral contraceptive containing oestradiol valerate/dienogest: A pooled analysis of three studies conducted in North America and Europe via openalex
- Hormone withdrawal-associated symptoms: Comparison of oestradiol valerate/dienogest versus ethinylestradiol/norgestimate via openalex
- Impact of estrogen type on cardiovascular safety of combined oral contraceptives via openalex
- <p>Contraception with estradiol valerate and dienogest: adherence to the method</p> via openalex
- Metabolic and Haemostatic Effects of Estradiol Valerate/Dienogest, a Novel Oral Contraceptive via openalex
- Preliminary Study on the Effect of Four-phasic Estradiol Valerate and Dienogest (E2V/DNG) Oral Contraceptive on the Quality of Sexual Life via openalex
- Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol via openalex
- The shorter, the better: A review of the evidence for a shorter contraceptive hormone-free interval via openalex
- doi:10.1186/s12905-015-0226-x via openalex
- doi:10.1080/00224499.2015.1134425 via openalex
- doi:10.1007/s00404-015-3726-x via openalex
- doi:10.3109/13625187.2012.728643 via openalex
- doi:10.3109/09513590.2014.922947 via openalex
- doi:10.3390/jcm8060908 via openalex
- doi:10.1111/jsm.12310 via openalex
- doi:10.1080/13625187.2019.1629412 via openalex
- doi:10.1186/1472-6874-13-9 via openalex
- doi:10.18565/aig.2016.2.108-113 via openalex
- doi:10.3109/09513590.2012.651931 via openalex
Cited by (2)
Source provenance
- openalex
- last seen: 2026-05-10T10:33:41.836352+00:00
License: CC0
· commercial use OK